The rapid rise of diabetic patients is estimated to be the most crucial factor driving the global diabetic retinopathy market. The increasing demand for diagnostic tests for diabetic retinopathy is estimated to escalate the market growth additionally. Further, the rise in the geriatric population is projected to play an important role in developing the global market. The growing favorable reimbursement policies, technical development, increasing incidence of blindness due to diabetes are anticipated to propel the market growth during the assessment period. Besides, the rise in disposable income and the rising concern towards the vision have led to an increase in expenditure of the individuals to avail of the treatment. Further, the minimal pain-inducing laser process with fast recovery is estimated to promote the market further in the coming period.